Search alternatives:
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
21
Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
22
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
23
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
24
Mean conidial viability of <i>Beauveria</i> and <i>Metarhizium</i> isolates.
Published 2024Subjects: -
25
-
26
-
27
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
28
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
29
-
30
-
31
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
32
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
33
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
34
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
35
-
36
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
37
Mean persistence (±SE) of GO and GO-GA NPs on <i>Callosobruchus maculatus.</i>
Published 2025Subjects: -
38
-
39
-
40